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Background
Extended spectrum b-lactamase (ESBL) especially, the
CTX-M producing Escherichia coli has emerged world
wide as the leading cause of community onset UTI in the
era of antibiotic resistance. The CTX-M producers often
exhibit co-resistance towards fluoroquinolones and are a
growing challenge to patient care. The purpose of this
study was to determine the incidence of fluoroquinolone
resistance among CTX-M producing uropathogenic
E.coli (UPEC).
Methods
UPEC isolated from HIV (n=76) and non-HIV antenatal
patients (n=42) were screened for ESBL production as per
CLSI guidelines. blaCTX-M was detected by PCR. Suscept-
ibility to ciprofloxacin was assessed as per CLSI guidelines.
Fisher’s exact test (two tailed) was employed to analyze
the statistical significance of the results.
Results
ESBL producers were more common among the UPEC
isolates from HIV compared to those from non-HIV
patients (75% vs 52.4%, p=0.015, OR=2.7273). Significant
difference was observed in the incidence of blaCTX-M
among the ESBL producers from HIV and non-HIV
patients (70.2% vs 31.8%, p=0.002, OR=5.042). Compared
to the CTX-M non-producers, majority of the CTX-M
producers were resistant to ciprofloxacin in both the
groups (HIV, 92.5% Vs 58.8%, p=0.0037, OR=8.6333, and
non-HIV, 71.4% vs 20%, p= 0.5235, OR=10).
Conclusion
Fluoroquinolones are the most common non-b lactam
antibiotic used in the treatment of infections caused by
ESBL producing organisms. The results of our study
suggest the possible emergence of plasmid mediated
fluoroquinolone resistance among the CTX-M produ-
cing E. coli. The co-resistance exhibited by the CTX-M
producers is a cause of concern, as it might facilitate the
co-selection process.
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